A novel KCND3 gain-of-function mutation associated with early-onset of persistent lone atrial fibrillation

Cardiovascular Research

Volumn 98, Issue 3, 2013, Pages 488-495

  Olesen, Morten Salling ^a,b   Refsgaard, Lena ^a,b   Holst, Anders Gaarsdal ^a,b   Larsen, Anders Peter ^a,c   Grubb, Søren ^a,b   Haunsø, Stig ^a,b   Svendsen, Jesper Hastrup ^a,b   Olesen, Søren Peter ^a,b   Schmitt, Nicole ^a,b   Calloe, Kirstine ^a  

^a DANISH NATIONAL RESEARCH FOUNDATION   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Brugada syndrome; KV4.3; KCND3; KCNIP2; Transient outward potassium current

Indexed keywords

ADULT; ALLELE; ARTICLE; CHO CELL; CONTROLLED STUDY; FEMALE; GAIN OF FUNCTION MUTATION; GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN CELL; KCND3 GENE; KCNIP2 GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ATRIAL FIBRILLATION; BRUGADA SYNDROME; KCND3; KCNIP2; KV4.3; TRANSIENT OUTWARD POTASSIUM CURRENT;

ADULT; AGE OF ONSET; ANIMALS; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; CHO CELLS; CRICETINAE; CRICETULUS; DENMARK; ELECTROCARDIOGRAPHY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KV CHANNEL-INTERACTING PROTEINS; MALE; MEMBRANE POTENTIALS; MUTATION; PHENOTYPE; POTASSIUM; SHAL POTASSIUM CHANNELS; TRANSFECTION; YOUNG ADULT;

EID: 84877958196     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt028     Document Type: Article

References (41)

1. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98: 946-952.
2. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL et al. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysi-ology. Circulation 2001;104:2118-2150.
3. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-2375.
4. Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart 2001;86:516-521.
5. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van HG, Stricker BH et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006;27:949-953.
6. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004; 110:1042-1046.
7. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002;415:219-226.
8. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997;96:2455-2461.
9. Fox CS, Parise H, D'Agostino RB Sr, Lloyd-Jones DM, Vasan RS, Wang TJ et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004;291: 2851-2855.
10. Oyen N, Ranthe MF, Carstensen L, Boyd HA, Olesen MS, Olesen SP et al. Familial aggregation of lone atrial fibrillation in young persons. J Am Coll Cardiol 2012;10:917-921.
11. Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007; 448:353-357.
12. Campuzano O, Brugada R. Genetics of familial atrial fibrillation. Europace 2009;11: 1267-1271.
13. Kozlowski D, Budrejko S, Lip GY, Rysz J, Mikhailidis DP, Raczak G et al. Lone atrial fibrillation: what do we know? Heart 2010;96:498-503.
14. Mahida S, Lubitz SA, Rienstra M, Milan DJ, Ellinor PT. Monogenic atrial fibrillation as pathophysiological paradigms. Cardiovasc Res 2011;89:692-700.
15. Olesen MS, Holst AG, Svendsen JH, Haunso S, Tfelt-Hansen J. SCN1Bb R214Q found in 3 patients: 1 with Brugada syndrome and 2 with lone atrial fibrillation. Heart Rhythm 2012;9:770-773.
16. Olesen MS, Yuan L, Liang B, Holst AG, Nielsen N, Nielsen JB et al. High prevalence of long QT syndrome-associated SCN5A variants in patients with early-onset lone atrial fibrillation. Circ Cardiovasc Genet 2012;5:450-459.
17. Christophersen IE, Olesen MS, Liang B, Andersen MN, Larsen AP, Nielsen JB et al. Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillation. Eur Heart J 2012, http://eurheartj. oxfordjournals.org/content/early/2012/12/20/eurheartj.ehs442. long.
18. Moe GK. Evidence for reentry as a mechanism of cardiac arrhythmias. Rev Physiol Biochem Pharmacol 1975;72:55-81.
19. Giudicessi JR, Ye D, Tester DJ, Crotti L, Mugione A, Nesterenko VV et al. Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. Heart Rhythm 2011;8:1024-1032.
20. Giudicessi JR, Ye D, Kritzberger CJ, Nesterenko VV, Tester DJ, Antzelevitch C et al. Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained death. Hum Mutat 2012;33:989-997.
21. Patel SP, Campbell DL. Transient outward potassium current, 'Ito', phenotypes in the mammalian left ventricle: underlying molecular, cellular and biophysical mechanisms. J Physiol 2005;569:7-39.
22. Niwa N, Nerbonne JM. Molecular determinants of cardiac transient outward potassium current (I(to)) expression and regulation. J Mol Cell Cardiol 2009;48:12-25.
23. Lundby A, Ravn LS, Svendsen JH, Hauns S, Olesen SP, Schmitt N. KCNE3 mutation V17M identified in a patient with lone atrial fibrillation. Cell Physiol Biochem 2008; 21:47-54.
24. Olesen MS, Bentzen BH, Nielsen JB, Steffensen AB, David JP, Jabbari J et al. Mutations in the potassium channel subunit KCNE1 are associated with early-onset familial atrial fibrillation. BMC Med Genet 2012;60:24.
25. Olesen MS, Jespersen T, Nielsen JB, Liang B, Moller DV, Hedley P et al. Mutations in sodium channel beta-subunit SCN3B are associated with early-onset lone atrial fibrillation. Cardiovasc Res 2011;89:786-793.
26. Lundby A, Jespersen T, Schmitt N, Grunnet M, Olesen SP, Cordeiro JM et al. Effect of the I(to) activator NS5806 on cloned K(V)4 channels depends on the accessory protein KChIP2. Br J Pharmacol 2010;160:2028-2044.
27. Radicke S, Cotella D, Graf EM, Banse U, Jost N, Varro A et al. Functional modulation of the transient outward current Ito by KCNE b-subunits and regional distribution in human non-failing and failing hearts. Cardiovasc Res 2006;71:695-703.
28. Xie C, Bondarenko VE, Morales MJ, Strauss HC. Closed-state inactivation in Kv4.3 isoforms is differentially modulated by protein kinase C. Am J Physiol Cell Physiol 2009;297:C1236-C1248.
29. Calloe K, Nof E, Jespersen T, Di Diego JM, Chlus N, Olesen SP et al. Comparison of the effects of a transient outward potassium channel activator on currents recorded from atrial and ventricular cardiomyocytes. J Cardiovasc Electrophysiol 2011;22:1057-1066.
30. Courtemanche M, Ramirez RJ, Nattel S. Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model. Am J Physiol 1998; 275:H301-H321.
31. Ritchie MD, Rowan S, Kucera G, Stubblefield T, Blair M, Carter S et al. Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation. J Am Coll Cardiol 2012;60:1173-1181.
32. Olesen MS, Holst AG, Jabbari J, Nielsen JB, Christophersen IE, Sajadieh A et al. Genetic loci on chromosomes 4q25, 7p31, and 12p12 are associated with onset of lone atrial fibrillation before the age of 40 years. Can J Cardiol 2012;28:191-195.
33. Workman AJ, Kane KA, Rankin AC. Cellular bases for human atrial fibrillation. Heart Rhythm 2008;5:S1-S6.
34. Pandit SV, Berenfeld O, Anumonwo JM, Zaritski RM, Kneller J, Nattel S et al. Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. Biophys J 2005;88:3806-3821.
35. Calloe K, Cordeiro JM, Di Diego JM, Hansen RS, Grunnet M, Olesen SP et al. A transient outward potassium current activator recapitulates the electrocardiograph-ic manifestations of Brugada syndrome. Cardiovasc Res 2009;81:686-694.
36. Delpón E, Cordeiro JM, Núñez L, Bloch-Thomsen PE, Guerchicoff A, Pollevick GD et al. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythmia Electrophysiol 2008;1:209-218.
37. Ohno S, Zankov DP, Ding WG, Itoh H, Makiyama T, Doi T et al. KCNE5 (KCNE1L) variants are novel modulators of Brugada syndrome and idiopathic ventricular fibrillation. Circ Arrhythm Electrophysiol 2011;4:352-361.
38. An WF, Bowlby MR, Betty M, Cao J, Ling HP, Mendoza G et al. Modulation of A-type potassium channels by a family of calcium sensors. Nature 2000; 403: 553-556.
39. Bahring R, Dannenberg J, Peters HC, Leicher T, Pongs O, Isbrandt D. Conserved Kv4 N-terminal domain critical for effects of Kv channel-interacting protein 2.2 on channel expression and gating. J Biol Chem 2001;276:23888-23894.
40. Callsen B, Isbrandt D, Sauter K, Hartmann LS, Pongs O, Bahring R. Contribution of N-and C-terminal Kv4.2 channel domains to KChIP interaction. J Physiol 2005;568: 397-412.
41. Sergeant GP, Ohya S, Reihill JA, Perrino BA, Amberg GC, Imaizumi Y et al. Regulation of Kv4.3 currents by Ca2+/calmodulin-dependent protein kinase II. Am J Physiol Cell Physiol 2005;288:C304-C313.